Duan Chongling, An Lin
Department of PET/CT, Jining NO.1 People's Hospital, Shandong First Medical University, Jining, Shandong Province, China.
Medicine (Baltimore). 2025 Jul 25;104(30):e43595. doi: 10.1097/MD.0000000000043595.
Individuals with end-stage renal disease have a considerably higher rate of malignant tumors, especially renal cancer, in comparison to the general population. However, cases in which bone metastases in the humerus are the initial clinical presentation that results in a diagnosis of renal cancer are extremely rare. Diagnosing renal cancer in patients with end-stage renal disease can be challenging when the clinical symptoms are atypical and do not present the "renal cancer triad." Our case report highlights the diagnostic importance of positron emission tomography/computed tomography (CT) imaging, increases clinicians' awareness of the disease, explores the potential etiology of renal cancer associated with end-stage renal disease, and provides insights into diagnostic and therapeutic strategies.
A 58-year-old man, who has undergone multiple renal transplants and maintenance dialysis therapy for over 20 years due to renal failure, arrived at our hospital with complaints of left shoulder pain and progressive worsening. CT revealed unexplained osteolytic destruction and fracture in the left humerus. The 18F-fluorodeoxyglucose positron emission tomography/CT scan detected soft tissue lesions in the left kidney and exhibited increased fluorodeoxyglucose uptake.
Upon conducting a biopsy on the patient's left humerus, metastatic renal cancer was diagnosed.
The patient selected conservative treatment, and the injured humerus was immobilized to stabilize the affected area. There was no additional active treatment for renal cancer.
As of the time of submission, the patient's pain had markedly intensified, requiring oral pain medication for symptomatic relief.
It is indeed rare for bone metastasis in the humerus to be the initial clinical sign that leads to the diagnosis of renal cancer in patients with end-stage renal disease. Through this case report, we aimed to enhance awareness and deepen understanding of renal cancer associated with end-stage renal disease.
与普通人群相比,终末期肾病患者的恶性肿瘤发生率显著更高,尤其是肾癌。然而,以肱骨骨转移作为导致肾癌诊断的初始临床表现的病例极为罕见。当终末期肾病患者的临床症状不典型且未出现“肾癌三联征”时,诊断肾癌可能具有挑战性。我们的病例报告强调了正电子发射断层扫描/计算机断层扫描(CT)成像的诊断重要性,提高了临床医生对该疾病的认识,探讨了与终末期肾病相关的肾癌的潜在病因,并提供了诊断和治疗策略的见解。
一名58岁男性,因肾衰竭接受多次肾移植及维持性透析治疗20余年,因左肩疼痛且进行性加重前来我院就诊。CT显示左肱骨有不明原因的骨质溶解破坏及骨折。18F-氟脱氧葡萄糖正电子发射断层扫描/CT检查发现左肾有软组织病变,且氟脱氧葡萄糖摄取增加。
对患者左肱骨进行活检后,诊断为转移性肾癌。
患者选择保守治疗,对受伤的肱骨进行固定以稳定患部。未对肾癌进行额外的积极治疗。
截至提交本文时,患者疼痛明显加剧,需要口服止痛药物以缓解症状。
在终末期肾病患者中,肱骨骨转移作为导致肾癌诊断的初始临床体征确实罕见。通过本病例报告,我们旨在提高对与终末期肾病相关的肾癌的认识并加深理解。